Screening assays for agonists and antagonists of receptor activator of NF-.kappa.B

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6884598
APP PUB NO 20020086312A1
SERIAL NO

09957944

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for screening for a molecule that antagonizes or agonizes RANK activity. One aspect of the invention involves the growth of RANK responsive cells in semi-solid medium, wherein exposure to a RANK antagonist promotes colony formation. Other aspects of the invention rely on promoter/reporter constructs using RANK responsive promoters derived from the MMP-9 and TRAP genes. Additional aspects of the invention exploit the ability of RANK to activate c-src activity, F-actin ring formation and CaPO.sub.4 resorption.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNEX CORPORATIONONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dougall, William C Seattle, WA 12 187

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation